Suppr超能文献

成人肾小球系膜细胞(HMCs)表达内皮素B受体,该受体介导内皮素-1诱导的细胞生长。

Adult human mesangial cells (HMCs) express endothelin-B-receptors which mediate endothelin-1-induced cell growth.

作者信息

Orth S R, Amann K, Gehlen F, Unger L, Wagner J, Raschack M, Ritz E

机构信息

Department of Internal Medicine, Ruperto Carola University Heidelberg, Germany.

出版信息

J Cardiovasc Pharmacol. 2000 Nov;36(5 Suppl 1):S232-7. doi: 10.1097/00005344-200036051-00069.

Abstract

Endothelin (ET) receptor antagonists are nephroprotective in renal damage models of the rat. It is unknown whether ET receptor antagonists are also beneficial in human renal diseases. Major differences exist between the ET systems in rats and humans, therefore this study was designed to characterize the ET receptors expressed on human adult mesangial cells (HMCs). HMCs cultures are a surrogate model for the development of glomerulosclerosis. Binding experiments with [125I]ET-1 in the presence or the absence of the test compounds [endothelin-1, -3 (ET-1, ET-3), sarafotoxin 6c (S6c), or BQ123] revealed an affinity (IC50 values) of 10.5 nm for ET-1 and 87.6 nm for ET-3. The affinities of the ET(B) agonist S6c and the ET(A) antagonist BQ123 were 85.9 nm and > 10 microm, respectively. Thus, the ET receptor on HMCs shows an ET(B)-like pharmacology, but in contrast to the classical ET(B)-receptor the affinities are low. No affinity for BQ123 up to > 10 microm excludes the presence of ET(A)-receptors. Functional studies using microfluorimetry (fura-2 method) showed comparable biphasic calcium signals induced by 10 nm ET-1, ET-3 and S6c. This effect could not be inhibited by BQ123, but by the ET(B) antagonist BQ788. Reverse transcriptase polymerase chain reaction (RT-PCR) studies under different culture conditions showed that both ET(A)- and ET(B)-receptor mRNAs are expressed in HMCs. The amount of ET(A)-receptor mRNA increased 2.7-fold and that of the ET(B)-receptor mRNA 7.1-fold after stimulation with 10% fetal calf serum (FCS). ET-1, ET-3 and S6c stimulated HMCs growth (ET-1 > S6c > ET-3), but the magnitude of the effect of ET-1 is lower than reported in rat mesangial cells (rat MCs). The effect on HMCs growth could be inhibited by BQ788, but not by BQ123. Our data provide evidence for the expression of ET(B)-receptors on HMCs that are functionally active. This finding differs from the ET receptor expression in rat MCs as reported by others.

摘要

内皮素(ET)受体拮抗剂在大鼠肾损伤模型中具有肾保护作用。ET受体拮抗剂在人类肾脏疾病中是否也有益尚不清楚。大鼠和人类的ET系统存在重大差异,因此本研究旨在表征成人人类系膜细胞(HMCs)上表达的ET受体。HMCs培养物是肾小球硬化发展的替代模型。在存在或不存在测试化合物[内皮素-1、-3(ET-1、ET-3)、沙拉毒素6c(S6c)或BQ123]的情况下,用[125I]ET-1进行的结合实验显示,对ET-1的亲和力(IC50值)为10.5nm,对ET-3的亲和力为87.6nm。ET(B)激动剂S6c和ET(A)拮抗剂BQ123的亲和力分别为85.9nm和>10μm。因此,HMCs上的ET受体表现出类似ET(B)的药理学特性,但与经典的ET(B)受体相比,亲和力较低。高达>10μm时对BQ123无亲和力排除了ET(A)受体的存在。使用微量荧光测定法(fura-2法)进行的功能研究表明,10nm ET-1、ET-3和S6c诱导的双相钙信号具有可比性。这种效应不能被BQ123抑制,但能被ET(B)拮抗剂BQ788抑制。在不同培养条件下进行的逆转录聚合酶链反应(RT-PCR)研究表明,ET(A)和ET(B)受体mRNA在HMCs中均有表达。用10%胎牛血清(FCS)刺激后,ET(A)受体mRNA的量增加了2.7倍,ET(B)受体mRNA的量增加了7.1倍。ET-1、ET-3和S6c刺激HMCs生长(ET-1>S6c>ET-3),但ET-1的作用强度低于大鼠系膜细胞(大鼠MCs)中的报道。对HMCs生长的影响可被BQ788抑制,但不能被BQ123抑制。我们的数据为功能活跃的HMCs上ET(B)受体的表达提供了证据。这一发现与其他人报道的大鼠MCs中的ET受体表达不同。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验